Aurobindo Pharma Ltd. | Cash Flow
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
15,325
21,679
27,443
30,608
32,412
Depreciation, Depletion & Amortization
3,125
3,326
3,924
4,276
5,580
Other Funds
2,298
4,803
7,108
7,853
8,549
Funds from Operations
16,153
20,201
24,259
27,031
29,443
Changes in Working Capital
10,591
8,417
10,794
5,341
10,358
Net Operating Cash Flow
5,562
11,784
13,465
32,372
19,085
Capital Expenditures
3,905
7,683
15,657
16,942
15,299
Sale of Fixed Assets & Businesses
164
224
1,380
95
2,893
Purchase/Sale of Investments
4,003
124
277
1,179
7,337
Net Investing Cash Flow
8,223
14,239
14,554
18,025
19,848
Cash Dividends Paid - Total
596
1,805
1,616
1,372
2,641
Issuance/Reduction of Debt, Net
2,675
3,408
6,033
17,279
12,022
Net Financing Cash Flow
2,114
1,671
4,490
18,584
9,383
Net Change in Cash
549
770
3,400
4,237
8,620
Free Cash Flow
1,657
4,101
2,192
15,431
3,786
Net Assets from Acquisitions
242
6,860
-
-
-
Other Sources
-
-
-
-
960
Change in Capital Stock
35
68
72
67
2
Exchange Rate Effect
1
15
-
-
-
Other Uses
237
44
-
-
1,065
About Aurobindo Pharma
View Profile
